Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Combo Product GMP Reg Speeds Ahead Unchanged

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency decides to keep the proposed rule, issued in 2009, “largely identical” and denies requests to delay implementation a year.

Advertisement

Related Content

Device Industry Seeks More Clarity Following Combo Product GMP Final Rule
Industry Seeks More Clarity Following Combo Product GMP Final Rule
For Combination Product Development, Industry Says Talk Is Cheap
CDER-Only Reviews Increase For Combination Products With Stand-Alone Devices, But Issues Remain
FDA Combination Products Office Finalizing Manufacturing, Adverse Event Rules
Company Questions Remain Unanswered In FDA's Combo Products GMP Rule

Topics

Advertisement
UsernamePublicRestriction

Register

PS074779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel